Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

Teddy Rosenbluth
Author: Teddy Rosenbluth

Written by

Teddy Rosenbluth

in

Appointments and Executive Changes, Cassava Sciences Inc, City College of New York, Clinical Trials, Drugs (Pharmaceuticals), Falsification of Data, Research, Securities and Commodities Violations
←Biden’s Student Loan Repayment Plan Blocked by Federal Appeals Court
Imagery Of A Bloodied Trump And Calls To ‘Fight’ Are Everywhere At The RNC→

More posts

  • Last House Democrat who voted against the ACA survives primary scare

  • ‘Wheel of Fortune’ Jim Thornton Featured on Tuesday’s Show Amid Sony Investigation

  • Victor Miller Dies: ‘Friday The 13th’ Screenwriter Was 86

  • Markey shrugs off Moulton in generational clash: 3 takeaways from Massachusetts primaries

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube